Rhythm Pharmaceuticals Stock (NASDAQ: RYTM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 93.00 / 493.44K |
Day Range | - - - |
52 Wk Range | 20.97 - 55.64 |
Market Cap | $3.23B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 23.91% |
Days to Cover | 28.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) through any online brokerage.
Other companies in Rhythm Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and TG Therapeutics (NASDAQ:TGTX).
Rhythm Pharmaceuticals has a consensus price target of $49.50.
The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $52.8 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.